514
Views
6
CrossRef citations to date
0
Altmetric
Articles

Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease

, , , , , , ORCID Icon & ORCID Icon show all
Pages 2587-2592 | Received 03 Jan 2022, Accepted 01 Mar 2022, Published online: 09 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hye Sung Han, Young Gue Koh, Jun Ki Hong, Yoon Jin Roh, Seong Jun Seo & Kui Young Park. (2023) Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis. Journal of Dermatological Treatment 34:1.
Read now

Articles from other publishers (5)

Maddalena Napolitano, Francesca di Vico, Angelo Ruggiero, Gabriella Fabbrocini & Cataldo Patruno. (2023) The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis. Frontiers in Medicine 10.
Crossref
Julián Londoño, Lucia Perez, Sergio Moreno, Edgardo Chapman, María Beatriz Garcia, Ana María Celis, María Angélica Muñoz, David Castillo, Jorge Sánchez, Yaicith Arevalo, Ana Lozano, Nelson J. Alvis-Zakzuk, Cesar Muñoz, Laura Botero, Catalina Beltran & Elizabeth García. (2023) Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience. World Allergy Organization Journal 16:4, pages 100763.
Crossref
Peng Cao, Wenjing Xu, Shuyi Jiang & Litao Zhang. (2023) Dupilumab for the treatment of prurigo nodularis: A systematic review. Frontiers in Immunology 14.
Crossref
Boyang Zhou, Surong Liang, Shuai Shang, Lujing Xiang & Linfeng Li. (2022) The changes of eosinophil counts in patients after treatment of Dupilumab: A systematic review and meta‐analysis. Allergy 77:12, pages 3690-3694.
Crossref
Veronika Naumova, Evgeny Beltyukov, Katarzyna Niespodziana, Peter Errhalt, Rudolf Valenta, Alexander Karaulov & Darina Kiseleva. (2022) Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma. Frontiers in Immunology 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.